Pfizer Inc.: Business Strategies
1.0Introduction
Pfizer Inc. (Pfizer) a research-based, international biopharmaceutical company. Nevertheless, it is the largest world drug organisation as well as the top-selling drug in the world in 2011. There is five segments for Pfizer Inc. to supervise its procedures which are Primary Care;Oncology and Special care, Emerging markets and Establish products; Consumer healthcare and Animal health and Nutrition Moreover, Pfizer freeze its position as one of the most diversified oranisation in the worldwide health care industry throughout strategic partnerships and acquisitions of diversified businesses, such as Wyeth.
1.1 current business strategies
Company's decision making management and senior-most leadership body is the main body of Pfizer which is the Pfizer's Executive Leadership Team (ELT). It carries collectively the peak leaders to spotlight on major operational decision, financial, and strategic for the organisation.
Pfizer has responded to today's biopharmaceutical R&D challenges with a rigorous strategy, Engine for Sustainable Innovation (ESI), innovating new capabilities, creating the R&D and portfolio are the three horizon centered to ensure stable ecosystem in the future. In 2011, Pfizer create important transform in R&D model to speed up the accomplishment of this plan, create an ongoing flow of essential improving return on invested capital and vaccines and medicine (www.Pfizer.com).
With the current business strategy, Pfizer willing to become a leader in biologics as well as enter the vaccines market to expand and invest to wins more areas. With the strengthen leadership, it able to merge the market with Wyth to make the position stronger. Create new opportunities for established products are because of the investment in complementary business (www.Pfizer.com).
1.1.2Competitive Advantages
The industry competitors of Pfizer are shown in Table 1 where the mayor three competitors regarding market size and product
Pfizer Inc. (Pfizer) a research-based, international biopharmaceutical company. Nevertheless, it is the largest world drug organisation as well as the top-selling drug in the world in 2011. There is five segments for Pfizer Inc. to supervise its procedures which are Primary Care;Oncology and Special care, Emerging markets and Establish products; Consumer healthcare and Animal health and Nutrition Moreover, Pfizer freeze its position as one of the most diversified oranisation in the worldwide health care industry throughout strategic partnerships and acquisitions of diversified businesses, such as Wyeth.
1.1 current business strategies
Company's decision making management and senior-most leadership body is the main body of Pfizer which is the Pfizer's Executive Leadership Team (ELT). It carries collectively the peak leaders to spotlight on major operational decision, financial, and strategic for the organisation.
Pfizer has responded to today's biopharmaceutical R&D challenges with a rigorous strategy, Engine for Sustainable Innovation (ESI), innovating new capabilities, creating the R&D and portfolio are the three horizon centered to ensure stable ecosystem in the future. In 2011, Pfizer create important transform in R&D model to speed up the accomplishment of this plan, create an ongoing flow of essential improving return on invested capital and vaccines and medicine (www.Pfizer.com).
With the current business strategy, Pfizer willing to become a leader in biologics as well as enter the vaccines market to expand and invest to wins more areas. With the strengthen leadership, it able to merge the market with Wyth to make the position stronger. Create new opportunities for established products are because of the investment in complementary business (www.Pfizer.com).
1.1.2Competitive Advantages
The industry competitors of Pfizer are shown in Table 1 where the mayor three competitors regarding market size and product